Breakthrough shot shields babies from deadly RSV
NCT ID NCT05110261
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single dose of nirsevimab, a lab-made antibody, in 800 healthy preterm and term infants in China to see if it could prevent serious lung infections caused by RSV. The goal was to reduce doctor visits and hospital stays during the RSV season. Results showed the treatment was safe and effective at lowering the risk of RSV-related illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER RESPIRATORY TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100191, China
-
Research Site
Changde, 415000, China
-
Research Site
Changsha, 410005, China
-
Research Site
Changsha, 410008, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Guangzhou, 510120, China
-
Research Site
Guangzhou, 510150, China
-
Research Site
Guangzhou, 510280, China
-
Research Site
Hangzhou, 310006, China
-
Research Site
Hangzhou, 310013, China
-
Research Site
Jiaxing, 314000, China
-
Research Site
Kunming, 650101, China
-
Research Site
Langfang, 065000, China
-
Research Site
Linfen, 041099, China
-
Research Site
Linfen, 41081, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Ningbo, 315012, China
-
Research Site
Sanmenxia, 472000, China
-
Research Site
Sanya, 572000, China
-
Research Site
Shantou, 515041, China
-
Research Site
Shaoxing, 311800, China
-
Research Site
Shenzhen, 518106, China
-
Research Site
Suzhou, 215002, China
-
Research Site
Tangshan, 63003, China
-
Research Site
Tianjin, 300201, China
-
Research Site
Wenzhou, 325027, China
-
Research Site
Xinxiang, 453000, China
-
Research Site
Zhengzhou, 450018, China
-
Research Site
Zhongshan, 528400, China